Literature DB >> 9341749

Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide.

L A Cotterill1, H J Stauss, M M Millrain, D J Pappin, D Rahman, B Canas, P Chandler, A Stackpoole, E Simpson, P J Robinson, P J Dyson.   

Abstract

The peptide-binding properties of the nonclassical major histocompatibility complex (MHC) class 1b molecule Qa-1 were investigated using a transfected hybrid molecule composed of the alpha 1 and alpha 2 domains of Qa-1b and the alpha 3 domain of H-2Db. This allowed the use of a monoclonal antibody directed against H-2Db whilst retaining the peptide-binding groove of Qa-1b. By comparison with classical MHC class I molecules, intracellular maturation of the chimeric molecule was inefficient with weak intracellular association with beta 2-microglobulin. However, at the cell surface the hybrid molecules were stably associated with beta 2-microglobulin and were recognized by cytotoxic T lymphocyte (CTL) clones specific for the Qa-1b-presented peptide Qdm (AMAPRTLLL). A whole-cell binding assay was used to determine which residues of Qdm were important for binding to Qa-1b and CTL clones served to identify residues important for T cell recognition. Substitutions at position 1 and 5 did not reduce the efficiency of binding and had little effect on CTL recognition. In contrast, substitutions at position 9 resulted in loss of MHC class I binding. Mass spectrometric analysis of peptides eluted from immunopurified Qa-1b/Db molecules indicated that Qdm was the dominant peptide. The closely related peptide, AMVPRTLLL, which is derived from the signal sequence of H-2Dk, was also present, although it was considerably less abundant. The mass profile suggested the presence of additional peptides the majority of which consisted of eight to ten amino acid residues. Finally, the finding that a peptide derived from Klebsiella pneumoniae can bind raises the possibility that this non-classical MHC class I molecule may play a role in the presentation of peptides of microorganisms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9341749     DOI: 10.1002/eji.1830270902

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

Review 1.  Qa-1, a nonclassical class I histocompatibility molecule with roles in innate and adaptive immunity.

Authors:  Peter E Jensen; Barbara A Sullivan; Lisa M Reed-Loisel; Dominique A Weber
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  An affinity/avidity model of peripheral T cell regulation.

Authors:  Hong Jiang; Yilun Wu; Bitao Liang; Zongyu Zheng; Guomei Tang; Jean Kanellopoulos; Mark Soloski; Robert Winchester; Itamar Goldstein; Leonard Chess
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

3.  HLA-E-restricted regulatory CD8(+) T cells are involved in development and control of human autoimmune type 1 diabetes.

Authors:  Hong Jiang; Steve M Canfield; Mary P Gallagher; Hong H Jiang; Yihua Jiang; Zongyu Zheng; Leonard Chess
Journal:  J Clin Invest       Date:  2010-09-27       Impact factor: 14.808

Review 4.  Diverse roles of non-diverse molecules: MHC class Ib molecules in host defense and control of autoimmunity.

Authors:  Amelia R Hofstetter; Lucy C Sullivan; Aron E Lukacher; Andrew G Brooks
Journal:  Curr Opin Immunol       Date:  2010-10-21       Impact factor: 7.486

5.  Perceiving the avidity of T cell activation can be translated into peripheral T cell regulation.

Authors:  Weiling Chen; Linging Zhang; Bitao Liang; Yvonne Saenger; Jianfeng Li; Leonard Chess; Hong Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

6.  Vaccine-Mediated Inhibition of the Transporter Associated with Antigen Processing Is Insufficient To Induce Major Histocompatibility Complex E-Restricted CD8+ T Cells in Nonhuman Primates.

Authors:  Shaheed A Abdulhaqq; Helen Wu; John B Schell; Katherine B Hammond; Jason S Reed; Alfred W Legasse; Michael K Axthelm; Byung S Park; Aravind Asokan; Klaus Früh; Scott G Hansen; Louis J Picker; Jonah B Sacha
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

7.  Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells.

Authors:  R E Vance; A M Jamieson; D H Raulet
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

8.  Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes.

Authors:  J R Kraft; R E Vance; J Pohl; A M Martin; D H Raulet; P E Jensen
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

9.  The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects.

Authors:  Cláudia C Oliveira; Peter A van Veelen; Bianca Querido; Arnoud de Ru; Marjolein Sluijter; Sandra Laban; Jan W Drijfhout; Sjoerd H van der Burg; Rienk Offringa; Thorbald van Hall
Journal:  J Exp Med       Date:  2009-12-28       Impact factor: 14.307

10.  Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b).

Authors:  R E Vance; J R Kraft; J D Altman; P E Jensen; D H Raulet
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.